Order results by:
| Issue | Title | |
| Vol 12, No 1 (2020) | Drug-induced tardive dyskinesia | Abstract similar documents |
| T. M. Ostroumova, V. A. Tolmacheva, O. D. Ostroumova, V. A. Parfenov | ||
| "... Tardive dyskinesia (TD) is a type caused by the use of different medications. The pathogenesis ..." | ||
| Vol 11, No 4 (2019) | Antipsychotic-induced tardive dyskinesia as a serious adverse effect in the psychopharmacotherapy of schizophrenia | Abstract similar documents |
| E. E. Vaiman, N. A. Shnayder, N. G. Neznanov, R. F. Nasyrova | ||
| "... -induced adverse effects (AEs) that stigmatize patients and worsen quality of life. Tardive dyskinesia (TD ..." | ||
| Vol 17, No 2 (2025) | Drug-induced dyskinesia when taking Fluvoxamine | Abstract similar documents |
| A. A. Katok, D. M. Khasanova, I. A. Khasanov | ||
| "... have a beneficial effect in tardive dyskinesia and chorea, but the mechanisms of this effect are still ..." | ||
| Vol 12, No 1 (2020) | Pharmacogenetics of drug-induced dyskinesias in Parkinson's disease | Abstract similar documents |
| A. A. Tappakhov, T. E. Popova, T. G. Govorova, N. A. Shnaider, M. R. Sapronova | ||
| "... in the frequency and time to onset of drug-induced dyskinesias. Therefore, genetic predisposition can play ..." | ||
| Vol 12, No 5 (2020) | Drug-induced dystonia | Abstract PDF (Eng) similar documents |
| T. M. Ostroumova, V. A. Tolmacheva, O. D. Ostroumova, V. A. Parfenov | ||
| "... Drug-induced dystonia (DID) is a rarely diagnosed adverse reaction to a sufficiently large number ..." | ||
| Vol 4, No 3 (2012) | Clinical experience with requip modutab | Abstract similar documents |
| Denis Valeryevich Zakharov, V A Mikhailov | ||
| "... are recommended as the drugs of choice as monotherapy and in combination with levodopa to enhance the efficiency ..." | ||
| Vol 6, No 3 (2014) | Current therapy for Parkinson's disease | Abstract similar documents |
| A. V. Obukhova | ||
| "... fluctuations and drug-induced dyskinesias. The currently available DRAs are the drugs of choice for the therapy ..." | ||
| Vol 14, No 2 (2022) | Association between redox imbalance, pterin metabolism markers, and early extrapyramidal side effects of antipsychotics in schizophrenia: pilot study | Abstract similar documents |
| T. V. Zhilyaeva, D. S. Shvachkina, A. S. Piatoikina, E. S. Zhukova, O. V. Kostina, T. G. Shcherbatyuk, G. E. Mazo | ||
| "... neurons in the EP system may be related to tardive dyskinesia and Parkinson's disease (PD) development ..." | ||
| Vol 4, No 2 (2012) | Capacities of the dopamine receptor agonist pramipexole in the treatment of patients with Parkinson’s disease | Abstract similar documents |
| S N Illarioshkin | ||
| "... symptoms and drug-induced dyskinesias so DRA are the drugs of choice and may be used alone and as part ..." | ||
| Vol 5, No 3 (2013) | The efficacy of the dopamine agonist Rotigotine in the treatment of Parkinson's disease | Abstract similar documents |
| Marina Romanovna Nodel | ||
| "... Rotigotine is a new, non-ergot dopamine receptor agonist (DRA) formulated as a transdermal drug ..." | ||
| Vol 4, No 1 (2012) | Sustained-release pramipexole in the treatment of Parkinson’s disease | Abstract similar documents |
| Natalia Vladimirovna Fedorova | ||
| "... and therapy of already existing motor fluctuations and drug-induced dyskinesias. Once-daily dosing of ERP ..." | ||
| Vol 5, No 1 (2013) | Practical aspects of the use of extended-release ropinirole (requip modutab) in the treatment of Parkinson’s disease | Abstract similar documents |
| Oleg Semenovich Levin, V K Datiyeva | ||
| "... and dyskinesias. Once-daily use of the drug and a more convenient dose titration scheme create conditions ..." | ||
| Vol 14, No 6 (2022) | A “new” role of amantadines in COVID-19 in patients with Parkinson’s disease: results of own comparative study | Abstract similar documents |
| Z. A. Zalyalova, S. E. Munasipova, D. M. Khasanova, G. R. Ilyina, Z. G. Khayatova, N. I. Bagdanova | ||
| "... dyskinesia (21%), hallucinations (3.5%). Patients taking amantadine sulfate had PD much longer (11.5±5 ..." | ||
| Vol 13, No 6 (2021) | Drug-induced parkinsonism | Abstract PDF (Eng) similar documents |
| T. M. Ostroumova, O. D. Ostroumova, A. S. Soloveva | ||
| "... Drug-induced parkinsonism (DIP) is the most common drug-induced movement disorder and is most ..." | ||
| Vol 14, No 2 (2022) | Drug-induced tremor | Abstract similar documents |
| T. M. Ostroumova, V. A. Tolmacheva, O. D. Ostroumova | ||
| "... Drug-induced tremor (DIT) is a term used to describe tremors that develop or increase in severity ..." | ||
| Vol 12, No 3 (2020) | Drug-induced cognitive impairment | Abstract similar documents |
| O. D. Ostroumova, M. I. Kulikova, T. M. Ostroumova, M. S. Chernyaeva, A. I. Kochetkov, V. A. Parfenov | ||
| "... commonly prescribed drugs, can cause cognitive impairment (CI). The negative effect of drugs on cognitive ..." | ||
| Vol 13, No 2 (2021) | Drug-induced hypersomnia | Abstract PDF (Eng) similar documents |
| T. M. Ostroumova, O. D. Ostroumova, A. V. Filippova, T. F. Guseva | ||
| "... and develop due to abuse and/or discontinuation of various medications. Drug- induced hypersomnia (DIH ..." | ||
| Vol 6, No 1S (2014): Special issue "Epilepsy" | Intravenous Antiepileptic Drugs in Russia | Abstract similar documents |
| P. N. Vlasov | ||
| "... Launching four intravenous antiepileptic drugs: valproate (Depakene and Convulex), lacosamide ..." | ||
| Vol 10, No 1S (2018): СПЕЦВЫПУСК: ЭПИЛЕПСИЯ | Generic substitutions of antiepileptic drugs: Is it possible to put an end to the discussion? | Abstract similar documents |
| E. A. Ushkalova, S. K. Zyryanov, K. E. Zatolochina | ||
| "... an epileptic patient may be switched from brand-name to generic antiepileptic drugs. The paper gives data ..." | ||
| Vol 10, No 2 (2018) | Effects of some commonly used drugs on cognitive functions | Abstract similar documents |
| O. D. Ostroumova, E. V. Shikh, E. V. Rebrova, A. G. Abrosimov | ||
| "... The paper discusses the effects of drugs from different pharmacological groups on cognitive ..." | ||
| Vol 10, No 1S (2018): СПЕЦВЫПУСК: ЭПИЛЕПСИЯ | Current approaches to neurosurgical treatment for drug-resistant focal epilepsy in adults | Abstract similar documents |
| E. A. Narodova, A. A. Narodov, N. A. Shnayder, D. V. Dmitrenko, I. G. Strotskaya | ||
| "... The review is dedicated to the problems of current neurosurgical treatment for drug-resistant ..." | ||
| Vol 13, No 6 (2021) | Generic drugs: benefit/risk ratio | Abstract similar documents |
| E. A. Ushkalova, S. K. Zyryanov, I. A. Gopienko | ||
| "... of original and generic drugs, and types of their equivalence, as well as problems with generics in clinical ..." | ||
| Vol 11, No 3S (2019): Спецвыпуск: когнитивные нарушения, цереброваскулярные заболевания | Non-drug therapies for cognitive impairment | Abstract similar documents |
| I. S. Preobrazhenskaya, D. Fantalis, S. A. Abdyshova, A. A. Kindarova | ||
| "... The review considers basic methods for non-drug correction of cognitive disorders, as well ..." | ||
| Vol 9, No 1 (2017) | Drug therapy for peripheral vestibular vertigo | Abstract similar documents |
| L. M. Antonenko, V. A. Parfenov | ||
| "... , by taking into account the high prevalence of peripheral vestibular diseases. Different drugs ..." | ||
| Vol 9, No 1S (2017): SPECIAL ISSUE: EPILEPSY | Drug interchangeability: Clinical efficacy and safety | Abstract similar documents |
| S. K. Zyryanov, S. B. Fitilev, I. I. Shkrebneva, A. V. Vozzhaev | ||
| "... The paper deals with the problem of the interchangeability of brand-name and generic drugs ..." | ||
| Vol 5, No 1S (2013): Special issue "Epilepsy" | The effect of antiepileptic drugs on cognitive functions | Abstract similar documents |
| A. S. Kotov | ||
| "... effects of antiepileptic drugs. Their cognitive effects are one of the major problems affecting ..." | ||
| Vol 5, No 1S (2013): Special issue "Epilepsy" | Effect of drug formulation on the treatment of epilepsy | Abstract similar documents |
| S. G. Burd | ||
| "... The paper describes a trial dealing with the effect of the formulation of an antiepileptic drug ..." | ||
| Vol 4, No 3 (2012) | Current drug treatments for vestibular disorders | Abstract similar documents |
| Maksim Valeryevich Zamergrad | ||
| "... , drug treatments for vertigo are being continued under development. The paper considers the current ..." | ||
| Vol 1, No 3-4 (2009) | RUSSIAN OBSERVATIONAL SURVEY OF THE SHORT-TERM EFFICACY AND TOLERABILITY OF SUSTAINED-RELEASE SODIUM VALPROATE (DEPAKINE CHRONOSPHERA®) AS A FIRST-LINE DRUG IN THE TREATMENT OF EPILEPSY | Abstract similar documents |
| E. D. Belousova, A. Yu. Ermakov | ||
| "... antiepileptic drugs (AED). The follow-up lasted at least 2 months. Results. The most common reason for using ..." | ||
| Vol 5, No 1 (2013) | Epilepsy and pregnancy: current therapeutic tactics | Abstract similar documents |
| Pavel Nikolayevich Vlasov, V A Karlov, V A Petrukhin | ||
| Vol 1, No 1 (2009) | THERAPY FOR EPILEPSY IN MIDDLE-AGED AND ELDERLY PATIENTS | Abstract similar documents |
| P. N. Vlasov, O. V. Andreeva | ||
| "... and somatic diseases, and a relative efficacy of small-dose antiepileptic drugs (AED). Choice of therapy ..." | ||
| Vol 1, No 1 (2009) | ETORICOXIB: THERAPEUTIC POTENTIAL | Abstract similar documents |
| A. E. Karateev | ||
| "... The paper describes the therapeutic properties of nonsteroidal anti-inflammatory drugs (NSAID ..." | ||
| Vol 15, No 4 (2023) | Pharmacokinetic parameters, safety and drug-drug interactions of mirtazapine and tizanidine, combined in the new original drug Dorsumio® | Abstract similar documents |
| A. S. Goncharov, A. V. Grigoriev, A. A. Globenko, I. S. Goncharov, K. A. Muratov, D. V. Yaroshenko, A. A. Sidorova, A. V. Kapashin, O. V. Kovchan, A. I. Bashkatova, M. A. Pasko | ||
| "... volunteers in comparison with Calixta®, a monocomponent drug (INN: Mirtazapine, filmcoated tablets, 30 mg ..." | ||
| Vol 13, No 2 (2021) | Drug-induced (medication-induced) depression in neurology practice | Abstract similar documents |
| E. Yu. Ebzeeva, O. D. Ostroumova, S. V. Batyukina, T. M. Ostroumova, A. I. Kochetkov, A. A. Kirichenko | ||
| "... One of the depression causes is the use of certain drugs, and in this case, the term drug-induced ..." | ||
| Vol 14, No 6 (2022) | Drug-induced non-traumatic intracranial hemorrhage associated with the use of anticoagulants and antiplatelet agents | Abstract similar documents |
| O. D. Ostroumova, A. I. Listratov, T. M. Ostroumova, A. I. Kochetkov, D. A. Sychev | ||
| "... are antithrombotic drugs: anticoagulant, antiplatelet and thrombolytic. The main risk factors for ICH are advanced ..." | ||
| Vol 13, No 1 (2021) | Modern approaches to drug treatment for vestibular vertigo | Abstract similar documents |
| M. V. Zamergrad, S. V. Morozova | ||
| "... vertigo consist of a gradually expanding arsenal of symptomatic and pathogenetic drugs. Among the drugs ..." | ||
| Vol 12, No 4 (2020) | Drug-induced headache: an analysis of therapeutic strategies | Abstract similar documents |
| P. A. Merbaum, G. R. Tabeeva, A. V. Sergeev | ||
| "... To manage patients with drug-induced headache (DIH) is an unsolved problem of modern neurology ..." | ||
| Vol 6, No 2S (2014): Special issue "Stroke" | Cognitive reserve and cognitive impairments: drug and nondrug treatments | Abstract similar documents |
| E.I. Dainikova, N.V. Pizova | ||
| "... for each patient to prevent dementia by drug and non-drug treatments. ..." | ||
| Vol 5, No 1S (2013): Special issue "Epilepsy" | Drug-resistant epilepsy associated with cortical dysplasias | Abstract similar documents |
| I. E. Poverennova, T. V. Kuznetsova | ||
| "... course and often induces drug-resistance in seizures. A group of patients with resistant seizures ..." | ||
| Vol 4, No 1S (2012): Special issue "Epilepsy" | New antiepileptic drugs, cost-efficacy analysis | Abstract similar documents |
| P. N. Vlasov, N. V. Orekhova, T. I. Konovalova | ||
| "... and cost-effectiveness of its therapy with the new antiepileptic drugs (AED): levetiracetam, lamotrigine ..." | ||
| Vol 4, No 2 (2012) | Capacities for the drug correction of functional disorders in posthypoxic encephalopathy | Abstract similar documents |
| M M Odinak, A Yu Emelin, V Yu Lobzin, S V Vorobyev | ||
| Vol 16, No 4 (2024) | Aviandr is a new original drug for treating anxiety | Abstract similar documents |
| V. A. Parfenov | ||
| "... , so the search for new drugs is needed. One of the new drugs that have been shown to be effective ..." | ||
| Vol 16, No 1S (2024): Спецвыпуск: Головная боль | Gastric stasis in migraine and the efficacy of antimigraine drugs | Abstract similar documents |
| G. R. Tabeeva, A. A. Kharitonova | ||
| Vol 9, No 1S (2017): SPECIAL ISSUE: EPILEPSY | Intellectual development of children born to mothers with epilepsy | Abstract similar documents |
| A. V. Yakunina, I. E. Poverennova, V. A. Kalinin, S. A. Ananyeva | ||
| "... groups of children. The comparison of the IQ scores in children who did not take antiepileptic drugs ..." | ||
| Vol 7, No 3 (2015) | Efficiency of epilepsy treatment in the Moscow Region under the present-day conditions of drug provision | Abstract similar documents |
| Irina Gennadyevna Rudakova, Yu. A. Belova | ||
| "... –2014 due to drug provision-related changes: the use of antiepileptic drugs (AEDs) in accordance ..." | ||
| Vol 6, No 1S (2014): Special issue "Epilepsy" | Experience of Using Vagus Nerve Stimulation to Treat Drug Resistant Epilepsy | Abstract similar documents |
| L. V. Lipatova, T. A. Skoromets, S. A. Gromov, S. D. Tabulina, A. V. Vtorov, M. M. Bondareva, A. G. Naryshkin, I. V. Galanin, S. A. Korovina, N. A. Sivakova, Yu. E. Mironenko | ||
| "... (VNS) in patients with drug resistance epilepsy (DRE). Patients and Methods. A VNS system was implanted ..." | ||
| Vol 5, No 1 (2013) | Thoracic spine pain | Abstract similar documents |
| Aleksey Ivanovich Isaikin, A V Kavelina | ||
| "... for thoracalgia includes a combination of non-drug and drug therapies. The cyclooxygenase 2 inhibitor meloxicam ..." | ||
| Vol 4, No 1 (2012) | Higher psychic dysfunctions in adult patients with epilepsy: role of antiepileptic therapy | Abstract similar documents |
| Kira Vladimirovna Voronkova, O A Pylayeva, I A Buchneva, T M Akhmedov | ||
| "... , including the use of antiepileptic drugs. Possible correction options are given for higher psychic sphere ..." | ||
| Vol 4, No 1 (2012) | Antyhypertensive therapy-based secondary prevention of ischemic stroke | Abstract similar documents |
| Vladimir Anatolyevich Parfenov, S V Verbitskaya, Yu A Starchina | ||
| "... -controlled trials of the use of different antihypertensive drugs in patients with prior stroke or transient ..." | ||
| Vol 1, No 2 (2009) | BACK PAIN AND ITS TREATMENT | Abstract similar documents |
| E. V. Podchufarova | ||
| Vol 16, No 2 (2024) | Efficacy of antiparkinsonian therapy in tremor correction according to tremorography | Abstract similar documents |
| V. A. Bogacheva, D. V. Zakharov, V. A. Mikhailov | ||
| "... Objective: to evaluate the efficacy of antiparkinsonian drugs of different groups considering ..." | ||
| Vol 14, No 1 (2022) | Drug-induced liver injury with cholestasis in the neurologist and psychiatric practice | Abstract PDF (Eng) similar documents |
| O. D. Ostroumova, E. V. Shikh, N. V. Shikh, T. M. Ostroumova, Y. A. Isaakyan | ||
| "... Among drug-induced liver injuries (DILI), the cholestatic type is second in frequency (from 20 ..." | ||
| Vol 12, No 4 (2020) | Severe drug-induced headache with its possible recurrent statuses in a patient with chronic tension headache | Abstract similar documents |
| V. V. Osipova, K. V. Skorobogatykh, A. R. Artemenko, A. V. Sergeev | ||
| "... The paper deals with the actual problem of managing patients with drug-induced headache (DIH ..." | ||
| Vol 17, No 1 (2025) | Tenoxicam. Pharmacological and clinical profile | Abstract similar documents |
| V. V. Afanasyev, D. A. Iskra | ||
| "... pharmacology of the non-steroidal anti-inflammatory drug (NSAID) tenoxicam (trade name – Texared®). Some ..." | ||
| Vol 13, No 3 (2021) | Profile and frequency of antiparkinsonian drugs adverse reactions: a systematic review and meta-analysis | Abstract similar documents |
| A. A. Tappakhov, T. E. Popova, A. I. Vasilev, T. G. Govorova, Yu. I. Khabarova, K. A. Timofeeva, N. A. Schnaider | ||
| "... Objective: to assess the predictors and prevalence of adverse drug reactions (ADRs) associated ..." | ||
| Vol 14, No 2 (2022) | Possibilities nootropic drugs in non-demented patients with vascular cognitive disorders | Abstract similar documents |
| M. N. Dadasheva, R. V. Gorenkov, V. A. Kruglov, K. N. Dadasheva, D. I. Lebedeva | ||
| Vol 14, No 1 (2022) | Kinesiotherapy and non-steroidal anti-inflammatory drugs for nonspecific lumbago | Abstract similar documents |
| A. A. Golovacheva, V. A. Golovacheva, V. A. Parfenov | ||
| "... -inflammatory drugs (NSAIDs) have a high level of evidence in chronic lumbago. Kinesiotherapy includes posture ..." | ||
| Vol 15, No 1 (2023) | Glioneuronal apoptosis and neuroinflammation in drug resistant temporal lobe epilepsy | Abstract similar documents |
| T. V. Sokolova, A. V. Litovchenko, N. M. Paramonova, V. R. Kasumov, S. V. Kravtsova, V. G. Nezdorovina, D. A. Sitovskaya, E. N. Skiteva, E. D. Bazhanova, Y. M. Zabrodskaya | ||
| "... drug-resistant epilepsy (DRE). Material and methods. Biopsy specimens of the cortex and white matter ..." | ||
| Vol 12, No 4 (2020) | Possibilities of drug therapy for vascular cognitive impairment: a critical view and possible compromises | Abstract similar documents |
| A. Yu. Emelin, V. Yu. Lobzin | ||
| "... drug therapy algorithms have not been elaborated, whereas the prescription of most drugs has not always ..." | ||
| Vol 12, No 6 (2020) | The use of perampanel in drug-resistant focal epilepsy: its effect on sleep | Abstract similar documents |
| A. A. Filin, M. V. Tardov, N. L. Kunelskaya, P. N. Vlasov | ||
| "... Perampanel (PER) is an antiepileptic drug (AED), the effects of which on sleep have not been ..." | ||
| Vol 11, No 2 (2019) | Differential chemoreactome analysis of synergistic combinations of tolperisone and nonsteroidal anti-inflammatory drugs | Abstract similar documents |
| I. Yu. Torshin, O. A. Gromova, L. V. Stakhovskaya, V. A. Semenov, A. N. Gromov | ||
| "... The concurrent use of muscle relaxants and nonsteroidal anti-inflammatory drugs (NSAIDs ..." | ||
| Vol 11, No 4 (2019) | Current requirements for studies of drugs for the pathogenetic treatment of multiple sclerosis | Abstract similar documents |
| A. N. Boyko, N. N. Spirin, Ya. V. Vlasov, M. N. Zakharova | ||
| "... More than 10 multiple sclerosis-modifying drugs (MSMDs) are widely used now. Novel MSMDs should ..." | ||
| No 1S (2016): | Partial epilepsies: Choice of antiepileptic drugs in adults in the outpatient setting | Abstract similar documents |
| P. N. Vlasov | ||
| "... drug in his practice under present-day conditions. It considers possible clinical situations ..." | ||
| Vol 10, No 1 (2018) | New drugs for anti-B-cell therapy of multiple sclerosis | Abstract similar documents |
| A. N. Boyko, N. Yu. Lashch, M. E. Guseva | ||
| "... for multiple sclerosis (MS) and the results of clinical trials of ocrelizumab, the first drug of this group ..." | ||
| Vol 9, No 1S (2017): SPECIAL ISSUE: EPILEPSY | Analysis of a case of drug-resistant childhood absence epilepsy concurrent with mysophobia | Abstract similar documents |
| V. A. Karlov, S. V. Ilyushenko, G. B. Novoselova | ||
| "... , and the development of alternative psychosis in an accentuated girl with drug-induced remission of absence seizures ..." | ||
| Vol 9, No 1S (2017): SPECIAL ISSUE: EPILEPSY | Rationale for mono- versus polytherapy with antiepileptic drugs for patients with epilepsy | Abstract similar documents |
| L. V. Lipatova, T. V. Kapustina | ||
| "... with epilepsy after failure of monotherapy with a first antiepileptic drug (AED). When choosing alternative ..." | ||
| Vol 7, No 3 (2015) | Pharmacoeconomic analysis of the use of first- and second-line drugs in the treatment of multiple sclerosis | Abstract similar documents |
| V. R. Mkrtchyan, L. V. Brylev, O. V. Davydova, A. V. Belyanin, I. A. Shpak, A. M. Sergeev | ||
| "... drugs in the treatment of multiple sclerosis through cost, cost-effectiveness, and budget impact ..." | ||
| Vol 6, No 2S (2014): Special issue "Stroke" | Drug therapy and cognitive stimulation in patients with poststroke cognitive impairments | Abstract similar documents |
| D.R. Khasanova, Yu.V. Zhitkova, L.M. Yu.V. | ||
| "... Objective: to compare a multimodal drug approach to treating poststroke cognitive impairments (CI ..." | ||
| Vol 6, No 2 (2014) | Experience with non-drug therapies (psychotherapy, phytotherapy, reflexotherapy) for neurasthenia | Abstract similar documents |
| S.A Bozhko, N.A. Tyuvina | ||
| "... of somatic complaints. Analysis of CGI data revealed the good therapeutic effect of a combination of non-drug ..." | ||
| Vol 4, No 2 (2012) | Back pain: Use of nonsteroidal anti-inflammatory drugs (nayz, ketorol) | Abstract similar documents |
| O B Doronina, B M Doronin, V B Doronin | ||
| "... , and comorbidity. Analgesics, nonsteroidal anti-inflammatory drugs (NSAIDs), and myorelaxants are effective ..." | ||
| 1 - 70 of 619 Items | 1 2 3 4 5 6 7 8 9 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
